Drug Pipeline

Repaglinide Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT05384626 A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors… Locally Advanced Solid Tumor Recruiting
Phase 1
NCT07372625 A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the… TP53 Y220C Mutation Recruiting
NCT07340190 A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the… Advanced Malignancies Not Yet Recruiting
Sponsors Running Repaglinide Trials
Nuvalent Inc. (1) Novartis Pharmaceuticals (1) PMV Pharmaceuticals, Inc (1)
Get alerts when Repaglinide trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free